Q&A with China based UMeWorld's (OTCQB: UMEWF) Discussing its Video Content Platform and Online Education Business

New York, NY, Point Roberts, WA - August 13, 2013 (Investorideas.com newswire) Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including social media and internet stocks issues an exclusive Q&A with the CEO and President of UMeWorld Limited (OTCQB: UMEWF), an online video and education internet company in China. Mr. Michael Lee, Chief Executive Officer and President share his vision of targeting the massive online market in China.

Q: Investorideas.com
Michael can you first explain briefly to new investors the two divisions of your internet company, the video content platform and the online education market?
A: Michael Lee, Chief Executive Officer and President
You probably are not aware that YouTube and many other popular video sites are blocked by China's "Great Firewall". UMeLook is uniquely positioned to offer advertisers the ability to use their existing promotional video assets to access mainland China consumers. UMeLook is deployed through a sophisticated CDN (Content Delivery Network) with broad coverage throughout mainland China. UMeLook is fast becoming the primary source of foreign video content for the Chinese viewer across any Internet-enabled device in China.
SmartStar is our cloud-based, adaptive learning educational platform, under our digital education business division. Unlike traditional online courseware, SmartStar provides a concept-level assessment and evaluation of a student’s learning progress. It identifies the student’s strengths, weaknesses, their proficiency in a given subject area and personalizes the delivery of proprietary educational items according to the student’s learning needs. SmartStar is also capable of providing scoring and statistical analysis of exams and evaluations and to provide administration of local and nationally standardized exams. It is ideal for schools and teachers.
Q: Investorideas.com
With the UMeLook ( http://www.umelook.com/) website can you explain how having foreign content differentiates your site in China?
A: Michael Lee, Chief Executive Officer and President
UMeLook.com is a niche player in the Chinese online video market, wherein the competition is focused on local TV series and, we different ourselves by focusing on foreign videos of less than 10 minutes duration and target affluent Chinese viewers between the age of 18-45 who are interested in foreign information, products and brands. UMeLook.com has also succeeded in entering the Chinese online video market where global players such as YouTube and Dailymotion are blocked and inaccessible in China. There is no existing direct competitor for UMeLook operations plan and business model in the Chinese online video marketplace.
Q: Investorideas.com
What kind of growth are you seeing for UMeLook ( http://www.umelook.com/) and how do you plan to keep building on that?
A: Michael Lee, Chief Executive Officer and President
More than 60% of China's approximately 600 million internet users watch online videos. As the number of China's internet users grows, so will the online video market. Chinese are spending much of their time online -- an average three hours a day, compared with two hours watching television, according to a study conducted last year by Starcom Mediavest Group. The statistic is the same for consumers even in the less developed, lower-tier markets that brands are keen to crack. UMeLook.com will continue to drive viewership aggressively and in conjunction, are preparing to launch a global e-commerce platform assisting small and medium brands from worldwide sources, to expand into the Chinese market. Marketers spent $7.4 billion on online marketing in China in 2011, representing 13.5% of total media spending. That was up from $5.1 billion, or 10.6% of the total, spent in 2010. We hope to generate significant advertising revenue from our e-commerce platform.
Q: Investorideas.com
The online education market has the potential to be huge according to analysts, filling the gaps in traditional education. How are you targeting that market and what kind of traction is the company getting?
A: Michael Lee, Chief Executive Officer and President
SmartStar is on track to become a leading education service provider in China. The K-12 education system in China is the largest in the world comprising 230 million students and 12 million teachers. Chinese families spend more discretionary income on education than anything other expense, except for housing. SmartStar will be available through a monthly subscription, as low as US$10, enabling the user to have unlimited access via the internet. We are in advance discussions with several national distributors who will offer SmartStar pre-paid cards that can be used against a monthly subscription.
Q: Investorideas.com
In closing Michael, what do you see as your biggest competitive advantage moving forward?
A: Michael Lee, Chief Executive Officer and President
Well, I am happy to say that there is no existing direct competitor for UMeLook operations plan and business model in the Chinese online video marketplace. As for SmartStar, our adaptive learning concept and technology is unique and in fact, we are about to submit a patent application to the patent office in U.S. and China to protect this asset. In conclusion, we are delivering two first-in-class products to meet the unmet needs of the target markets and there is no reason not to be successful.
About UMeWorld
UMeWorld's mission is to facilitate the interaction between people -- "You" and "Me," through its digital platform. Currently, UMeWorld operates UMeLook ( http://www.umelook.com/), an online video platform focused on bringing foreign video content to China. UMeLook is deployed through a sophisticated CDN (Content Delivery Network) with broad coverage throughout mainland China, Hong Kong & Taiwan. UMeLook plans to be a source of foreign video content for the Chinese viewer across any Internet-enabled device in China. UMeWorld intends to focus its future operations on digital media and the digital education market.
About InvestorIdeas.com: Big Ideas for global investors
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for free stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: UMEWF compensates Investorideas.com for news publication and syndication: two thousand per month
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 or 212-822-8842 Source - www.Investorideas.com

Investors Have an Appetite for "Healthy" IPOs and New Public Companies in LOHAS Sector

New York, NY, Point Roberts, WA - August 14, 2013 (www.investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including food and beverage stocks issues a sector snapshot for publicly traded companies with a focus on healthy and organic products . Based on the consumer reaction to this sector, it has proven to be one of the few trends that has been recession proof and has therefore been attractive to investors.

With the success stories of Whole Foods ( NASDAQ: WFM) and The Hain Celestial Group ( NASDAQ: HAIN) paving the path for other companies, the market has seen successful IPOs and new company listings that evidence that this trend is not going away any time soon.
Irwin Simon, CEO of the Hain Celestial Group ( NASDAQ: HAIN) was featured in Forbes Magazine August 12 th issue in an article entitled Juiced Up: Inside $3.5 Billion Organic Giant Hain Celestial, Whole Foods' Biggest Supplier. The organic food trend is riding high and Wall Street and Main Street are both benefiting.
Just this month Sprouts Farmers Market ( NASDAQ: SFM) made their market debut, ringing the opening bell with an IPO priced to the public at $18.00. The sector scored another big winner, with the stock now trading in the $38.00 range.
Other Recent market entries include Noodles & Company ( NASDAQ:NDLS ) priced to the public at $18.00 per share in June 2013, giving investors a double the first day and is now trading around $41.00.
Smaller companies in the sector recently trading on the junior OTC markets include Microlog Corporation ( OTC: MLOG ) DBA NutraBev Holdings International, Inc, a holding company that acquires businesses in the healthy lifestyle marketplace. The company’s focus is on the consumables portion of the nutritional supplement and organic food/beverage market segments. The company completed its first acquisition in May 2013, Silverbow Honey, a honey manufacturing and distribution business located in Moses Lake, Washington.
The health and nutrition market is an estimated $84 billion. Discussing the market and their strategy, David Sackler, CEO of MLOG says that “the health and nutrition space is rapidly growing as people age and become more aware of what they are eating and how that affects their lifestyle and health. We believe there is a significant consolidation opportunity for companies in the sector and are working on participating in that market opportunity.”
The company ( OTC: MLOG) just announced the completion of the acquisition of NutraBev Holdings in late July and is now in the process of updating the company’s reporting and regulatory status.
GRILLiT ( OTC: GRLT ), a growing Latin-Caribbean fusion restaurant concept that marries fast casual to nutritious and healthy food has taken investors for a wild ride in the past month, running from around $.20 to a high of $5.25 and is currently trading around $3.25.
As the markets fluctuated with ups and downs over the last few years, the LOHAS sector continued to grow, with some of the most successful IPOs over the last 10 years. Even during the worst of 2008, Whole Foods stayed consistently strong in revenues and stock price, showing that consumers won’t budge on local, sustainable and organic choices.
It’s a sector to watch for consumers and investors betting on a healthier world. According to Lohas.com, “the Lifestyles of Health and Sustainability market is an estimated $290 billion U.S. market for goods and services focused on health, the environment, social justice, personal development and sustainable living and the power of the growing consumer market remains virtually untapped.”
About InvestorIdeas.com: Big Ideas for global investors
Investorideas.com provides a list of LOHAS (Lifestyles of health and sustainability) stocks for interested investors
http://www.investorideas.com/LOHAS-investing/
www.InvestorIdeas.com is a meeting place for investors and public companies in leading sectors. Find investing ideas, news and research for biotech stocks, tech and mobile stocks, mining stocks, oil and gas, water stocks, renewable energy, beverage stocks, defense stocks, nanotech and more on TSX, OTC, NASDAQ and global stock exchanges.
Follow Investorideas.com on Twitter
Follow Investorideas.com on Facebook
Follow Investorideas.com News on Linkedin.com/today
Sign up for free stock alerts at Investorideas.com
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas has been compensated for news publishing and content marketing : ( three thousand five hundred first month plus 17,500 restricted shares for month two) for two month period) http://www.investorideas.com/About/Disclaimer.asp Warning this company is not fully reporting at this time: more info: http://www.otcmarkets.com/stock/MLOG/quote BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894 800-665-0411 -   Source - www.Investorideas.com
800-665-0411
Source - www.Investorideas.com

Canada and U.S. Businesses Invited to Macrorrueda; Business Matchmaking Colombian Style

New York, Point, Roberts, WA - August 13, 2013 (www.investorideas.com newswire) Investorideas.com, an investor research portal specializing in investing ideas for global investors, reports on business developments and opportunities at the upcoming Proexport Colombia event, "Macrorrueda", which will be held in Chicago on September 4-5th.

Colombia's economy is currently the third largest in Central and South America and its proactive global promotion of business and investment opportunities will stake their claim for future growth.
The Macrorrueda event creates a unique forum for investment and business opportunities between Canada, USA, and Columbia. It creates a face- to- face personal venue to explore business opportunities in a format similar to "speed-dating". Canadian and U.S. buyers will be given an assigned table identified by a number where the Colombian Exporters will rotate during their 40-minute appointments. It's not as fast as the Salsa that Colombia is so well- known for but buyers should have their best dancing shoes on to go through each potential partner during the course of the day.
Trade Commissioner Alvaro Concha has recently been in New York, Toronto and Montreal promoting this year's event, with a primary focus on Colombia's tourism, investment and exportation sectors. Proexport's "Magical Realism" tourism ad campaign was launched earlier this year and is a big part of the overall strategy to make the world aware of the dramatic changes in Colombia in the past few years. Canadians seem to be getting the message loud and clear as more and more tourists find their way to Colombia each year.
With Free Trade Agreements in place with both Canada and the U.S., trade and investment are on the rise and expected to continue as Proexport spreads the word about how business friendly Colombia has become. Alvaro Concha said in Vancouver Canada in June that Proexport's goal is to make Colombia the "shining star in the South American constellation".
Asked about Macrorrueda, "Colombia has seen an overall increase in the number of non-mining exports to Canada following the enforcement of the FTA, but the diversification of our products has been one of the biggest benefits," said Concha. "Through events like the Macrorrueda in Chicago, Proexport ensures that Canadian companies see the breadth of our exports and can take advantage of the reduced tariffs and quotas."
Macrorrueda will also feature products and services by Colombian companies from the Agribusiness, Manufacturing and Apparel sectors. From exotic and tropical fruits, flowers, herbs, coffee, cocoa and natural cosmetics; there is a full line of products within each sector to bring back the passion and spice of Colombia to North America.
Language will not be a barrier, as translation services will be provided if needed and a Proexport representative will be assigned to each table during the business meetings if the business owners feel its necessary.
Macrorrueda events have successfully taken place in the past, resulting in new business opportunities with Colombian exporters.
For business owners seeking opportunities in South America, Colombia is a gateway of opportunity, not just to products in Colombia but also its surrounding countries.
Investorideas.com has covered business and investing opportunities in Colombia in a series of articles in 2013. Read more about Colombia:
Investorideas.com Q&A with Juan Carlos Gonzalez, Foreign Investment Vice-President at Proexport Colombia
http://www.investorideas.com/news/2013/main/07251.asp
Magical Realism: The Reality VS Perception of Investing in Colombia
http://www.investorideas.com/news/2013/main/06241ep.asp
Go South Young Man; The Pacific Alliance Presents A New Frontier of Investment Opportunities at Alianza del Pacifico, Cali, Colombia
http://www.investorideas.com/news/2013/mining/05291.asp
Investorideas.com Q&A with Maria Constanza Garcia, President of Colombia's National Mining Agency
http://www.investorideas.com/news/2013/mining/03262.asp
About Proexport:
Proexport Colombia is the organization in charge of promoting Colombia as an international tourist destination, attracting foreign investment and fostering non-traditional exports.
Through their national and international office network, they provide support and comprehensive assistance to national entrepreneur, through offering services with the aim of facilitating the design and execution of its internationalization strategy, seeking the generation and tracking of business opportunities. To learn more about Proexport visit www.proexport.com.co
More about Macrorrueda:
http://www.macrorruedasproexport.com/
About Alvaro Concha:
Alvaro Concha was appointed Trade Commissioner for the Canadian headquarters of Proexport in 2011. Mr. Concha has more than 15 years of experience on international commerce following his experiences as Trade Commissioner for the offices of Italy and the Northern Triangle of Central America. He identified, defined and adjusted the strategies for the promotion of exports and positioning of Colombia as an investment and tourism destination in new markets. Mr. Concha holds an MBA from the European School of Business in Madrid.
He advanced one of the most strategic locations for Proexport in the world, following the implementation of the Free Trade Agreement between Canada and Colombia. Identified defined and adjusted strategies for promotion, market access and positioning for Colombian products in the country. Additionally, Mr. Concha implemented business and marketing plans for the growth and expansion of trade between Canada and Colombia. While constantly monitoring markets for new opportunities, Mr. Concha diligently identified new opportunities for Colombian companies in various scenarios and industries.
About InvestorIdeas.com: Big Ideas for Global Investors
www.InvestorIdeas.com is a global leader in investor sector research, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy and beverage stocks.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities.
800-665-0411 - Source - www.Investorideas.com

Mobile Payment Stock Alert: Calpian's (OTCQB: CLPI) Money-on-Mobile Serves over 62 Million Unique Users, Volume up 6% from June

DALLAS - August 7, 2013 (Investorideas.com newswire) Calpian, Inc. (OTCQB:CLPI) announced today that, as of July 31, 2013, the Money-on-Mobile service offered by its Indian subsidiary is now being supported by 151,530 retail locations, an increase of 8,473 stores from 143,057 stores on June 30, 2013. Additionally, Money-on-Mobile was accessed by approximately 62.6 million unique phone number customers as of July 31, 2013, up from the 57.8 million reported from the previous month. Processed transaction volume for July 2013, which is measured in Indian rupees, was slightly over 912.4 million INR, a gain of almost 53 million Rupees or about 6% from the previous month. At current exchange rates, July processed transaction volume was approximately $15 million.

According to Calpian CEO, Harold Montgomery, "We are extremely pleased with the consistent and steady growth of all three key metrics. We had previously added about 3,000 to 4,000 stores per month, but our marketing focused on key urban areas has increased store additions to over 8,000 this month. Month after month we are seeing further evidence of the increase in popularity of our Money-on-Mobile service."
Money-on-Mobile Managing Director Shashank Joshi said, "We are focusing our marketing resources to achieve deep penetration in key markets such as Kolkata and the effort is paying off now. In 2013, Money-on-Mobile has increased store count by over 29,000 locations - almost 24%. In July the rate of growth was higher than previous trends."
About Calpian, Inc.
Calpian, Inc. (CLPI) is a publicly traded company with corporate offices in Dallas , Texas , operating centers in Georgia , New York and Illinois and mobile payments emerging-market operations through its subsidiary in India.
Calpian's Indian subsidiary offers Money-on-Mobile, a pre-paid mobile payment solution, to more than 134,200 Indian retail locations. Calpian's management team has over 70 years in combined experience in the payments business. Calpian's CEO, Harold Montgomery, is a recognized industry leader who has provided expert testimony to the U.S. Congress and Federal Reserve Bank on payments-related issues and regularly appears in numerous industry publications, such as Transaction World Magazine. Please visit our website at www.calpian.com for more information.
Contact:
Calpian, Inc.
Harold Montgomery, 214-758-8600
Chief Executive Officer

Technical Breakout; Aethlon Medical (OTCQB: AEMD) Sets Record Trading Highs

Point Roberts, WA, New York, NY - August 7, 2013 (Investorideas.com newswire) Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including biotech and medical technology stocks, issues a technical trading alert for Aethlon Medical, Inc. (OTCQB: AEMD). The stock had a technical breakout and a significant 5 day run. Following breaking through its 52 week high of $.020, it traded up over 40% in yesterdays session to close at $0.27 on strong volume and momentum.

On July 18 th Zacks Small Cap Research issued an update entitled AEMD: Recent Progress Helps De-Risk Aethlon by Brian Marckx, CFA. The report included a pricing target for the stock that has since been surpassed.
Investors have reacted to a stream of positive news in the past several weeks including
FDA approval of an Investigational Device Exemption (IDE) that allows the Company to initiate human feasibility studies of the Aethlon Hemopurifier® in the United States. The Hemopurifier ® is a first-in-class medical device that targets the rapid elimination of life-threatening infectious disease and cancer glycopathogens from circulation.
Additionally the company announced a contract from the Defense Advanced Research Projects Agency, or DARPA, including partners Battelle, NxStage Medical (NASDAQ: NXTM), that represents a four year $22.83 million deal to design, develop, test and validate an advanced, portable medical device.
The most recent update was an announcement that the European Patent Office has provided Aethlon with a Decision to Grant a Patent entitled "METHOD OF REMOVAL OF VIRUSES FROM BLOOD BY LECTIN AFFINITY HEMODIALYSIS” has taken the stock to a new technical trading pattern.
The European Patent will be assigned Patent No. 1624784 and has been referenced in European Patent Office Bulletin No. 13/29.
August 6 th close
5 day chart
About Aethlon Medical (OTCQB: AEMD)
Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system. At present, The Aethlon ADAPT product pipeline includes the Aethlon Hemopurifier to address infectious disease and cancer, and a medical device being developed under a 5-year contract with DARPA to reduce the incidence of sepsis in combat-injured soldiers. For more information, please visit www.aethlonmedical.com.
Zacks research link:
http://finance.yahoo.com/news/aemd-recent-progress-helps-risk-110000781.html
About InvestorIdeas.com: Big Ideas for global investors
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter   http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook   http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for free stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech and medical technology stocks:
http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas has been compensated by AEMD for news release distribution and content publishing: three thousand per month effective June 2013 http://www.investorideas.com/About/Disclaimer.asp BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar
800-665-0411 or 212-822-8842Source - www.Investorideas.com

Stem Cell Stock Alert: BioRestorative Therapies (OTCBB: BRTX) Receives Approval to Conduct Retrospective Safety Study on its Bulging/ Herniated Disc Procedure

JUPITER, Fla. - August 6, 2013 (Investorideas.com Newswire) BioRestorative Therapies Inc. ("BRT" or the "Company") (OTCQB: BRTX), a life sciences company focused on developing stem cell based cellular therapies for various personal medical applications, today announced that it has received approval from the Western Institutional Review Board ("the Board") to complete a retrospective safety study on selected subjects previously treated by the Company's brtxDISC™ bulging and herniated disc procedure. The study is titled "Re-consenting and Follow-Up of Adults from a Retrospective Study Using Autologous Transplantation of Marrow Derived Mesenchymal Stem Cells to Degenerated Intervertebral Disc."

Study objectives are to determine the safety of subjects who received transplants of their own stem cells into their disc, using MRI and Quality of Life Questionnaires. The Board requires that all subjects must be able to consent for themselves to be enrolled in the study, which has been approved to take place at the Centeno-Schultz Clinic in Broomfield, Colorado.
The approval allows BRT to retrospectively collect and analyze clinical data on selected subjects who previously have been treated for bulging or herniated disc disease with the Company's novel brtxDISC™ procedure. These procedures were performed using BRT's proprietary therapeutic delivery device cannula system and its proprietary culture method isolating a selective population of mesenchymal stem cells. BRT expects to complete the study within a six-month period.
"This is a significant milestone in taking our brtxDISC™ procedure closer towards an FDA meeting to seek approval for the commencement of our clinical trial. We look forward to collecting this data with the ambition of meeting the safety requirements necessary for us to receive approval and start our trial," commented Mark Weinreb, Chief Executive Officer of BioRestorative Therapies. "Our goal is to compile and present the necessary data to the FDA with the goal of initiating a Phase I or Phase II clinical trial in the early part of next year."
About BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. ("BRT"), www.biorestorative.com, develops medical procedures using cell and tissue protocols, primarily involving adult stem cells, designed for patients to undergo minimally invasive cellular-based treatments. BRT is developing the following scientific initiatives:

• brtxDISC™ Program (Disc Implanted Stem Cells), a non-surgical treatment for bulging and herniated discs that addresses the gap between non-invasive and invasive back procedures. This research is still in the non-clinical, investigational stage.
• ThermoStem® Program, a treatment for metabolic disorders (diabetes, heart disease, etc.) and obesity using brown fat stem cells. Initial non-clinical research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels in the body.
• brtx-C Cosmetic Program, based on the development of a human cellular extract that, per initial in vitro studies, when applied to human skin cells, appears to cause an increase in the production of collagen and fibronectin, which are proteins that are essential to combating the aging of skin. Potential cosmetic uses are being explored with third parties.

The Company also offers plant stem cell-based facial creams and beauty products under the Stem Pearls® brand at www.stempearls.com.
This press release and the interview contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including those set forth in the Company's Form 10-K filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.
Investor Contact:
Adam Holdsworth
ProActive Capital
646.862.4607
adamh@proactivecapital.com
Media Contact:
Sandra Lee
ProActive Capital
646.862.4608
slee@proactivecapital.com
Disclaimer /Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk.
http://www.investorideas.com/About/Disclaimer.asp
This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: BioRestorative has compensated Investoridea for a six month news program ( five thousand ) to be published on Investorideas.com newswire and syndication and social media partners.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Medical Technology Stock Trading Alert: Aethlon Medical (OTCQB: AEMD) Trades at 52-Week High

Point Roberts, WA, New York, NY - August 6, 2013 (Investorideas.com newswire) Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including biotech and medical technology stocks, issues a trading alert for Aethlon Medical, Inc. (OTCQB: AEMD). The stock closed Monday’s trading session at $0.1870, gaining 0.0270 or 16.88% on over 1.9 Million shares. The stock traded as high as $0.20, its 52- week high.

The stock made its first run in July when it announced FDA approval of an Investigational Device Exemption (IDE) that allows the Company to initiate human feasibility studies of the Aethlon Hemopurifier® in the United States. The Hemopurifier ® is a first-in-class medical device that targets the rapid elimination of life-threatening infectious disease and cancer glycopathogens from circulation.
The next move was after news that Battelle, NxStage Medical (NASDAQ: NXTM), Inc. and Aethlon Medical (OTCQB: AEMD) won a contract from the Defense Advanced Research Projects Agency, or DARPA. The contract funded in phases and could be as large as $22.83 million and last as long as four years -- is for leading one of DARPA's DLT System Integration projects. The project calls for Battelle and key subcontractors, NxStage and Aethlon, to design, develop, test and validate an advanced, portable medical device that exhibits the technical innovation for which DARPA projects are known, and to coordinate integration of key technologies developed during the overall DLT program. This funding does not include human clinical trials that may be required prior to military use and/or United States Food and Drug Administration clearance for sepsis-treatment technologies.
Reaching these key milestones followed by news that that the European Patent Office has provided the Company with a Decision to Grant a Patent entitled "METHOD OF REMOVAL OF VIRUSES FROM BLOOD BY LECTIN AFFINITY HEMODIALYSIS” has taken the stock to a new technical trading pattern.
The European Patent will be assigned Patent No. 1624784 and has been referenced in European Patent Office Bulletin No. 13/29.
About Aethlon Medical (OTCQB: AEMD)
Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system. At present, The Aethlon ADAPT product pipeline includes the Aethlon Hemopurifier to address infectious disease and cancer, and a medical device being developed under a 5-year contract with DARPA to reduce the incidence of sepsis in combat-injured soldiers. For more information, please visit www.aethlonmedical.com.
About InvestorIdeas.com: Big Ideas for global investors
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for free stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech and medical technology stocks:
http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas has been compensated by AEMD for news release distribution and content publishing: three thousand per month effective June 2013 http://www.investorideas.com/About/Disclaimer.asp BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar
800-665-0411 or 212-822-8842
Source - www.Investorideas.com

Medical Technology Stock Trading Alert: Aethlon Medical (OTCQB: AEMD) Gains 21%

Point Roberts, WA, New York, NY - August 2, 2013 (Investorideas.com newswire) Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including biotech and medical technology stocks, issues a trading alert for Aethlon Medical, Inc. (OTCQB: AEMD), The stock is trading at 0.17, up 0.03 or 21.43% as of 2:25PM EDT on over 1.3 Million shares, with a high of $0.18.

In late July the company reported that Battelle, NxStage Medical (NASDAQ: NXTM), Inc. and Aethlon Medical (OTCQB: AEMD) won a contract from the Defense Advanced Research Projects Agency, or DARPA, to develop an innovative, new medical device that may save the lives of soldiers -- and civilians as well -- by treating sepsis.
The contract, funded in phases and could be as large as $22.83 million and last as long as four years -- is for leading one of DARPA's DLT System Integration projects. The project calls for Battelle and key subcontractors, NxStage and Aethlon, to design, develop, test and validate an advanced, portable medical device that exhibits the technical innovation for which DARPA projects are known, and to coordinate integration of key technologies developed during the overall DLT program. This funding does not include human clinical trials that may be required prior to military use and/or United States Food and Drug Administration clearance for sepsis-treatment technologies.
The company also reported in July FDA approval of an Investigational Device Exemption (IDE) that allows the Company to initiate human feasibility studies of the Aethlon Hemopurifier® in the United States. The Hemopurifier ® is a first-in-class medical device that targets the rapid elimination of life-threatening infectious disease and cancer glycopathogens from circulation.
Under the feasibility study protocol, Aethlon will enroll ten end stage renal disease (ESRD) patients who are infected with the Hepatitis C virus (HCV) to demonstrate the safety of Hemopurifier therapy. Successful completion of the feasibility study will set the stage for Aethlon to conduct pivotal studies required for market clearance to treat HCV and potentially other disease conditions.
About Aethlon Medical (OTCQB: AEMD)
Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system. At present, The Aethlon ADAPT product pipeline includes the Aethlon Hemopurifier to address infectious disease and cancer, and a medical device being developed under a 5-year contract with DARPA to reduce the incidence of sepsis in combat-injured soldiers. For more information, please visit www.aethlonmedical.com.
About InvestorIdeas.com: Big Ideas for global investors
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for free stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech and medical technology stocks:
http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas has been compensated by AEMD for news release distribution and content publishing: three thousand per month effective June 2013 http://www.investorideas.com/About/Disclaimer.asp BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar
800-665-0411 or 212-822-8842
Source - www.Investorideas.com

Social Media Stock UMeWorld's (OTCQB:UMEWF) Reports Video Platform Now Exceeds 4.7 Million Unique Visitors

HONG KONG - August 2, 2013 (Investorideas.com newswire) Social Media Stock Alert: MeWorld Limited (OTCQB: UMEWF) is pleased to announce that UMeLook.com, an online video platform focused on bringing foreign video content to China, had 4.7 million unique visitors and over 20 million page views in July 2013. UMeLook.com has seen a significant increase in viewer traffic after having completed a total redesign and a renewed focus on the user experience just two months ago. Visitors now spend an average of more than nine minutes on UMeLook.com per visit. UMeLook.com has achieved a ranking of 5,169 in China and 42,040 globally according to Alexa.

"I am thrilled with the latest key performance indicators, especially because we have achieved them in just a few months. We are not so far from monetizing our video platform with pre-roll, post-roll and banner advertisements," said Michael Lee, President & CEO of UMeWorld Limited.
About UMeWorld
UMeWorld's mission is to facilitate the interaction between people -- "You" and "Me," through its digital platform. Currently, UMeWorld operates UMeLook (www.umelook.com), an online video platform focused on bringing foreign video content to China. UMeLook is deployed through a sophisticated CDN (Content Delivery Network) with broad coverage throughout mainland China, Hong Kong & Taiwan. UMeLook plans to be a source of foreign video content for the Chinese viewer across any Internet-enabled device in China. UMeWorld intends to focus its future operations on digital media and the digital education market.
Forward Looking Statement
Statements in this press release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties. Words such as "expects," "intends," "plans," "may," "could," "should," "anticipates," "likely," "believes" and words of similar import also identify forward-looking statements. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. We assume no obligation to publicly update or revise any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release, even if new information becomes available in the future. For a more detailed description of the risk and uncertainties affecting the Company, reference is made to the Company's reports filed from time to time with the Securities and Exchange Commission.
For more information, please contact:
UMeWorld Limited
E-mail: info@UMeWorld.com
Published at Investorideas.com – Big Ideas for Global Investors
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: UMEWF compensates Investorideas.com for news publication and syndication : two thousand per month
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

How Google (GOOG), AT&T (T) and Technology Companies are Opening up the World

Point Roberts, WA, New York, NY - August 2, 2013 (Investorideas.com newswire) Investorideas.com, providing global investing ideas in leading sectors including technology, issues a sector snapshot on developments and the market opportunity for language coding (all Unicode & all ASCII) technology and software.  With apps like the AT&T Translator ( NYSE:T ) Google’s Android (NASDAQ :GOOG), The Bible App in 400 languages, all are working on changing worldwide DIGITAL communications.

Google is looking at how to take digital languages to the next level, and then it’s just a matter of time before language will no longer have any barriers and business and individuals will be able to communicate with anyone, anywhere in any language. And as Google says: they will bring everyone to the Internet by 2020.
A pioneer in the sector, Dr. Philip Payne, founder of Linguist's Software Inc. http://www.linguistsoftware.com/ , started his company 30 years ago in Edmonds, WA not knowing the path to globalization that lay ahead. He grew his company to provide fonts and input from 200 to over 2000 languages over the last three decades, making it by far the largest linguistic software library of its kind.  Now this new (IP) is ten times larger (language/font/key-guide & tool set) than Adobe, who used to be the world leader.
Ken Kinkel, CEO of Mergers & Acquisitions ( www.CorpMA.com ) represents Dr. Payne’s exit strategy and retirement from Linguist's Software Inc. and understands the value of his language software to change the future of mobile and the internet communications.
"Google has said they will have everyone on the Internet by 2020. They are moving so fast that only companies with these 2000+ languages could have a chance to catch up to Google.  Maybe even beat them, to what is now looking like a monopoly for Google by 2020. That’s an astonishing prediction and if it’s true, then the company that owns these 2,000 plus languages will be a perfect position to capitalize on this astonishing achievement.  Being connected worldwide is one thing, but being able to communicate in practically every language of the world is quite another.  Our client’s product makes this possible.  Universal connectivity and now matched with the available in one’s own language - a perfect combination for the future of worldwide digital communications.
Other firms may even beat Google, to what is now looking like a worldwide monopoly for them by 2020.  By using their cell phone dominance (and 6.3 billion cell phones that exist today, according to the UN) they could skip past the huge infrastructure that Google is now building in fiber, and power worldwide. And use existing cell technology to take these languages to world dominance right now and well before Google’s dominance by 2020.
Previous article reference:
How do you say "Apple" in 2000 Languages?
Linguist's Software Blazes the Path to Globalization for Web and Mobile Devices with Fonts and Keyboard Input for 2000 Languages
http://www.investorideas.com/news/2013/technology/07151ep.asp
About InvestorIdeas.com: Big ideas for global investors
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. Disclosure: Investorideas has been compensated for this article distribution http://www.investorideas.com/About/Disclaimer.asp
Source - www.Investorideas.com
Contact for more info on Linguist's Software, Inc.
Ken Kinkel CEO@CorpMA.com 1-855-559-0100 x11

Investorideas.com Launches Sponsored Investment Content, a New Way to Reach Targeted Investors and Consumers in Leading Sectors

Point Roberts, WA, New York, NY - August 1, 2013 (www.investorideas.com newswire) Investorideas.com staff: Investorideas.com, a global news source featuring investing ideas for independent investors, announces new sponsored content opportunities for stock and business news. The ad format creates a new way to reach a targeted and relevant investor or consumer audience.

The new sponsored content advertising program allows companies to insert content ads (an average of 800 characters) into the bottom of published content that has reached an audience through social media and syndication and has attracted relevant eyeballs.
This creates an opportunity for a smaller or competing company to place relevant content in an article, story or news release from a larger well- known brand or stock.
If a company does not have news of its own to publish for the week, this also creates an opportunity to tag other relevant news and reach an even larger potential audience with the right news source.
Investor Ideas publishes original investment research and news, global news and events, third party investment commentary from well- known and respected newsletter writers, as well as company news and press releases within leading sectors.
Content sponsorship includes investing ideas, trading alerts and stock news for biotech stocks, tech and mobile stocks, mining stocks, oil and gas, water stocks, renewable energy, beverage stocks, defense stocks, nanotech ( 14 sectors in total ) trading on the TSX, OTC, NASDAQ, NYSE, ASX and major global stock exchanges.
Investorideas.com newswire is a news source on Google News, Linkedin.com/today as well as global syndication partners, blogs and social media.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks, gaming, homebuilder and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for news alerts
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Contact us at 800-665-0411
More contact info and services info for Investor Ideas:
http://www.investorideas.com/Investors/Services.asp
Source - www.Investorideas.com

Stem Cell Stock Alert: BioRestorative Therapies (OTCBB: BRTX) Provides Company Updates with Shareholder Letter

JUPITER, Fla. - August 1, 2013 (Investorideas.com Newswire) BioRestorative Therapies Inc. ("BRT" or the "Company") (OTCQB: BRTX), a life sciences company focused on stem cell-based therapeutics, today announced the issuance of a shareholder letter by Chief Executive Officer, Mark Weinreb, providing an update to shareholders on the Company's progress.

The shareholders were advised as follows:
Over the past 12 months, BRT's substantial investment in research and development has allowed the Company to continue executing on its growth strategy. There have been many developments, both operationally and scientifically, that have positioned the Company well as a growing stem cell biotechnology company with a specific focus on cellular treatments and therapies for certain medical applications.
Below are some of the Company's accomplishments and activities over the past 12 months:

• In the latter part of 2012, BRT appointed Wayne A. Marasco, M.D., Ph.D. as Chairman of its Scientific Advisory Board. Dr. Marasco currently serves as an Associate Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute. He is head of Marasco Labs, an accomplished research laboratory at Dana-Farber Cancer Institute known for discovery and therapeutic human monoclonal antibody development and for constructing and validating various human-mouse chimeric models in the area of cancer, infectious disease immunotherapy, regenerative medicine and tissue engineering. Dr. Marasco is a Principal Faculty Member of the Harvard Stem Cell Institute and has extensive experience in the field of stem cells.
• Late last year, the Company announced that its common stock had begun trading on the OTC Bulletin Board. The company went through a very thorough and diligent review process by FINRA to attain the Bulletin Board listing. The Bulletin Board trading platform allows for more potential investors interested in purchasing the Company's stock. The Company is extremely pleased to provide investors increased visibility and transparency that this regulated quotation service provides.
• In late November, BRT launched its new website available at www.biorestorative.com. The new site highlights the Company as an innovator and pioneer in the adult stem cell industry. The Company's primary programs are highlighted in more detail on the website, along with rich imagery and information about therapies being developed.
• At the start of 2013, the Company was invited to present at the Adipose Tissue Biology conference of the Keystone Symposia conference series. Chief Scientist and Vice President of Research and Development, Francisco Silva, presented the Company's research on "Human Metabolically Active Brown Adipose Tissue Derived Stem Cells." This research is a result of the scientific work the Company has been performing pursuant to its ThermoStem® Program, which is in the pre-clinical stage and which focuses on treatments for metabolic disorders (particularly focusing on Type 2 diabetes) and obesity and uses adult derived stem cells from brown adipose (fat) tissue stem cells.
• On April 13th, Dr. Marasco spoke at the Second International Vatican Adult Stem Cell Conference: Regenerative Medicine -- A Fundamental Shift in Science and Culture. The event was held in Vatican City from April 11th to April 13th. Dr. Marasco spoke during the session entitled "Stem Cells, Cancer and Aging — A Search for Solutions." His talk was titled "What Questions Haven't Been Addressed with Respect to Stem Cells, Cancer and Aging?"
• In April, the Company was invited to present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria. Mr. Silva presented the Company's research on Human Metabolically Active Brown Adipose Tissue Derived Stem Cells. This research is a result of the scientific work the Company has been performing pursuant to its ThermoStem® Program.
• The Company hired ProActive Capital in mid-April to help increase awareness of the Company among the investment community. ProActive Capital is also helping to increase exposure through the use of social and digital media.
• In mid April, the Company implemented a 1-for-50 reverse stock split which reduced its outstanding shares from 820,641,011 to 16,412,820. 94% of the shares voted were in favor of the proposal. The Company believes the reverse split will help attract a new base of shareholders as well as new institutional and retail support in the market.
• In mid May, the Company signed an agreement with Dexterity, Inc., a product design and bioengineering firm, to further the development and production of its brtxDISC™ (Disc Implanted Stem Cells) stem cell therapy device. This device plays an integral role in delivering stem cells for its proprietary bulging/herniated disc therapy.
• In May, the Company once again presented its investment thesis at the Marcum MicroCap Conference. To listen to the webcast, please visit http://wsw.com/webcast/marcum/brtx. The event hosted nearly 100 publicly traded companies with capitalizations under $500 million and attracted more than 1,000 people, including senior personnel from the presenting public companies, leading institutional investors, directors, bankers and service providers to the microcap marketplace.
• At the end of May, the Company formally launched its "brtx-C Cosmetic" Program. The Company announced that it has developed a human cellular-derived extract that, per initial in vitro studies, when applied to skin cells, appears to cause a significant increase in collagen and fibronectin production (proteins that are essential for combating the aging of skin). The Company plans to conduct additional in vitro studies to better understand the extract's mechanism of action and human cellular activity and is actively seeking collaborations with other parties to commercialize the product.
• In mid June, financial personality and founder of NBT Equities Research, Tobin Smith, interviewed CEO Mark Weinreb with regard to the Company's hybrid business model and what it is currently doing that will help change the biotechnology landscape. Click here for the full interview: http://direct.nbtequitiesresearch.com/video/nbt-biorestorative-1
• In late June, the Company expanded its ThermoStem® Program by collecting 150 samples of human brown adipose tissue. This strengthens its R & D platform for the development of treatments for metabolic disorders and obesity. For the past year, through strategic collaboration and internal efforts, the Company has grown a large library of human brown fat stem cells. The compilation of a large number and variety of brown fat derived stem cells allows it to study and identify potential cell lines to be used in developing therapies.
• In mid July, the Company was featured in the industry publication, "The Life Sciences Report." In the interview included in the report, CEO Mark Weinreb described how the Company's cell therapy process could possibly keep disc disease treatment out of the operating theater. Link to full interview: http://www.thelifesciencesreport.com/pub/na/15470
• Since 2011, the Company has raised approximately $9 million, which has enabled it to achieve clear milestones as it continues to build momentum on its growth strategy.

"Based on these accomplishments, we are excited for what lies ahead in the near and long term," states CEO Mark Weinreb. "We continue to make speedy and efficient progress with our programs and look forward to further advancements regarding each of our exciting initiatives. I would like to thank all of our shareholders for their continued support. We will continue to work diligently to further execute our growth plan so that BioRestorative Therapies will be able to mature into a prominent life sciences company."
About BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. ("BRT"), www.biorestorative.com, develops medical procedures using cell and tissue protocols, primarily involving adult stem cells, designed for patients to undergo minimally invasive cellular-based treatments. BRT is developing the following scientific initiatives:

• brtxDISC™ Program (Disc Implanted Stem Cells), a non-surgical treatment for bulging and herniated discs that addresses the gap between non-invasive and invasive back procedures. This research is still in the non-clinical, investigational stage.
• ThermoStem® Program, a treatment for metabolic disorders (diabetes, heart disease, etc.) and obesity using brown fat stem cells. Initial non-clinical research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels in the body.
• brtx-C Cosmetic Program, based on the development of a human cellular extract that, per initial in vitro studies, when applied to human skin cells, appears to cause an increase in the production of collagen and fibronectin, which are proteins that are essential to combating the aging of skin. Potential cosmetic uses are being explored with third parties.

The Company also offers plant stem cell-based facial creams and beauty products under the Stem Pearls® brand at www.stempearls.com.
This press release and the interview contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including those set forth in the Company's Form 10-K filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.
Investor Contact:
Adam Holdsworth
ProActive Capital
646.862.4607
adamh@proactivecapital.com
Media Contact:
Sandra Lee
ProActive Capital
646.862.4608
slee@proactivecapital.com
Disclaimer /Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk.
http://www.investorideas.com/About/Disclaimer.asp
This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: BioRestorative has compensated Investoridea for a six month news program ( five thousand ) to be published on Investorideas.com newswire and syndication and social media partners.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

China Social Media Stock Alert: UMeWorld's (OTCQB:UMEWF) Video Platform Surpasses 4.7 Million Unique Visitors and Continues to Attract Chinese Viewers

HONG KONG - August 1, 2013 (Investorideas.com newswire) MeWorld Limited (OTCQB: UMEWF) is pleased to announce that UMeLook.com, an online video platform focused on bringing foreign video content to China, had 4.7 million unique visitors and over 20 million page views in July 2013. UMeLook.com has seen a significant increase in viewer traffic after having completed a total redesign and a renewed focus on the user experience just two months ago. Visitors now spend an average of more than nine minutes on UMeLook.com per visit. UMeLook.com has achieved a ranking of 5,169 in China and 42,040 globally according to Alexa.

"I am thrilled with the latest key performance indicators, especially because we have achieved them in just a few months. We are not so far from monetizing our video platform with pre-roll, post-roll and banner advertisements," said Michael Lee, President & CEO of UMeWorld Limited.
About UMeWorld
UMeWorld's mission is to facilitate the interaction between people -- "You" and "Me," through its digital platform. Currently, UMeWorld operates UMeLook (www.umelook.com), an online video platform focused on bringing foreign video content to China. UMeLook is deployed through a sophisticated CDN (Content Delivery Network) with broad coverage throughout mainland China, Hong Kong & Taiwan. UMeLook plans to be a source of foreign video content for the Chinese viewer across any Internet-enabled device in China. UMeWorld intends to focus its future operations on digital media and the digital education market.
Forward Looking Statement
Statements in this press release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties. Words such as "expects," "intends," "plans," "may," "could," "should," "anticipates," "likely," "believes" and words of similar import also identify forward-looking statements. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. We assume no obligation to publicly update or revise any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release, even if new information becomes available in the future. For a more detailed description of the risk and uncertainties affecting the Company, reference is made to the Company's reports filed from time to time with the Securities and Exchange Commission.
For more information, please contact:
UMeWorld Limited
E-mail: info@UMeWorld.com
Published at Investorideas.com – Big Ideas for Global Investors
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: UMEWF compensates Investorideas.com for news publication and syndication : two thousand per month
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Solar Stock Trading Alert: XsunX, Inc. (OTCQB: XSNX) Closes up 32%

New York, NY, Point Roberts, WA - July 31, 2013 (Investorideas.com renewable energy newswire) Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including renewable energy stocks, issues a trading alert for solar stock, XsunX, Inc. (OTCQB: XSNX). The stock closed trading on Tuesday July 30 th at $0.0085, gaining 0.0021 or 32.81% on over 4.4 Million shares.

The company issued a shareholder update Tuesday discussing recent activity in the stock as well as a corporate update on the technology. See http://www.xsunx.com/news.php?nid=366
Worldwatch (www.worldwatch.org) also said on Tuesday that, “Global use of solar and wind energy continued to grow significantly in 2012. Solar power consumption increased by 58 percent, to 93 terrawatt-hours (TWh), and the use of wind power increased by 18 percent, to 521 TWh. Although hydropower remains the world's leading renewable energy, solar and wind continue to dominate investment in new renewable capacity and are quickly becoming the highest-profile renewable energy sources. “
About XsunX (OTCQB: XSNX)
XsunX, Inc. is working to commercialize a new manufacturing process to produce low cost, high efficiency thin-film Copper Indium Gallium (di) Selenide (CIGS) thin film solar cells. Our patent-pending processing technology, which we call CIGSolar®, focuses on the mass production of thin-film CIGS solar cells utilizing a proprietary multi-area thermal deposition process to minimize processing defects to create highly uniform CIGS films. These cells match silicon solar cell dimensions and can be offered as a non-toxic, high-efficiency and lowest-cost alternative to the use of silicon solar cells. The company is offering licenses for the use of the CIGSolar® process technology, and plans to generate revenue through licensing fees and manufacturing royalties for the use of the CIGSolar® technology.
For more information please call XsunX at 888-797-4527, or visit the company's website at www.xsunx.com
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 14 online stock directories 24/7 – water, renewable energy, mining stocks and more…
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. Disclosure: Investorideas has been compensated by XSNX for news distribution averaging 1500 per month
http://www.investorideas.com/About/Disclaimer.asp
This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar
800-665-0411 - Source – www.Investorideas.com